Case Report: Infusion-Related Reactions to Intravenous Infliximab and Subcutaneous Ustekinumab in Pediatric Crohn's Disease

• Hoofdauteurs: Toshihiko Kakiuchi (Auteur), Sakiko Kimura (Auteur), Motohiro Esaki (Auteur), Muneaki Matsuo (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Although the biological agent ustekinumab (UST) is reported to be effective for Crohn's disease (CD) in pediatric as well as adult patients, data on the efficacy and safety of UST in pediatric patients with CD are limited. Here, we describe the case of a pediatric patient who showed...